PACK-CXL: Defining CXL for infectious keratitis

Journal of Refractive Surgery

Volumn 30, Issue 7, 2014, Pages 438-439

  Hafezi, Farhad ^a,b   Bradley Randleman, J ^c  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

REACTIVE OXYGEN METABOLITE; RIBOFLAVIN;

CHROMATOPHORE; COLLAGEN CROSS LINKAGE; CORNEA SURGERY; EDITORIAL; HUMAN; INFECTIOUS KERATITIS; KERATITIS; KERATOCONUS; PHOTOACTIVATION; PRIORITY JOURNAL; ULTRAVIOLET A RADIATION;

COLLAGEN; CORNEAL STROMA; CORNEAL ULCER; CROSS-LINKING REAGENTS; EYE INFECTIONS, BACTERIAL; HUMANS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; RIBOFLAVIN; TERMINOLOGY AS TOPIC; ULTRAVIOLET RAYS;

EID: 84904406531     PISSN: 1081597X     EISSN: 19382391     Source Type: Journal    
DOI: 10.3928/1081597X-20140609-01     Document Type: Editorial

References (24)

1. Spoerl E, Huhle M, Seiler T. Induction of cross-links in corneal tissue. Exp Eye Res. 1998;66:97-103. (Pubitemid 28070342)
2. Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. 2003;135:620-627. (Pubitemid 36457967)
3. Ehlers N, Hjortdal J, Nielsen K, Sondergaard A. Riboflavin-UVA treatment in the management of edema and nonhealing ulcers of the cornea. J Refract Surg. 2009;25:S803-S806.
4. Hafezi F, Kanellopoulos J, Wiltfang R, Seiler T. Corneal collagen crosslinking with riboflavin and ultraviolet A to treat induced keratectasia after laser in situ keratomileusis. J Cataract Refract Surg. 2007;33:2035-2040. (Pubitemid 350167516)
5. Kanellopoulos AJ. Comparison of sequential vs same-day simultaneous collagen cross-linking and topography-guided PRK for treatment of keratoconus. J Refract Surg. 2009;25:S812-S818.
6. Kymionis GD, Kontadakis GA, Kounis GA, et al. Simultaneous topography-guided PRK followed by corneal collagen cross-linking for keratoconus. J Refract Surg. 2009;25:S807-S811.
7. Price MO, Tenkman LR, Schrier A, Fairchild KM, Trokel SL, Price FW Jr. Photoactivated riboflavin treatment of infectious keratitis using collagen cross-linking technology. J Refract Surg. 2012;28:706-713.
8. Richoz O, Gatzioufas Z, Francois P, Schrenzel J, Hafezi F. Impact of fluorescein on the antimicrobial efficacy of photoactivated riboflavin in corneal collagen cross-linking. J Refract Surg. 2013;29:842-845.
9. Richoz O, Mavrakanas N, Pajic B, Hafezi F. Corneal collagen cross-linking for ectasia after LASIK and photorefractive keratectomy: long-term results. Ophthalmology. 2013;120:1354-1359.
10. Salgado JP, Khoramnia R, Lohmann CP, Winkler von Mohrenfels C. Corneal collagen crosslinking in post-LASIK keratectasia. Br J Ophthalmol. 2011;95:493-497.
11. Schrier A, Greebel G, Attia H, Trokel S, Smith EF. In vitro antimicrobial efficacy of riboflavin and ultraviolet light on Staphylococcus aureus, methicillin-resistant Staphylococcus aureus, and Pseudomonas aeruginosa. J Refract Surg. 2009;25:S799-S802.
12. Wollensak G, Aurich H, Wirbelauer C, Pham DT. Potential use of riboflavin/UVA cross-linking in bullous keratopathy. Ophthalmic Res. 2009;41:114-117.
13. Naseem I, Ahmad M, Hadi SM. Effect of alkylated and intercalated DNA on the generation of superoxide anion by riboflavin. Biosci Rep. 1988;8:485-492.
14. Kumar V, Lockerbie O, Keil SD, et al. Riboflavin and UV-light based pathogen reduction: extent and consequence of DNA damage at the molecular level. Photochem Photobiol. 2004;80:15-21.
15. Kumari MV, Yoneda T, Hiramatsu M. Scavenging activity of "beta catechin" on reactive oxygen species generated by photosensitization of riboflavin. Biochem Mol Biol Int. 1996;38:1163-1170. (Pubitemid 26334730)
16. Spoerl E, Wollensak G, Seiler T. Increased resistance of cross-linked cornea against enzymatic digestion. Curr Eye Res. 2004;29:35-40. (Pubitemid 39389439)
17. Iseli HP, Thiel MA, Hafezi F, Kampmeier J, Seiler T. Ultraviolet A/riboflavin corneal cross-linking for infectious keratitis associated with corneal melts. Cornea. 2008;27:590-594.
18. Makdoumi K, Mortensen J, Sorkhabi O, Malmvall BE, Crafoord S. UVA-riboflavin photochemical therapy of bacterial keratitis: a pilot study. Graefes Arch Clin Exp Ophthalmol. 2012;250:95-102.
19. Said DG, Elalfy MS, Gatzioufas Z, et al. Collagen cross-linking with photoactivated riboflavin (PACK-CXL) for the treatment of advanced infectious keratitis with corneal melting [published online ahead of print February 2, 2014]. Ophthalmology. doi:10.1016/j.ophtha.2014.01.011
20. Alio JL, Abbouda A, Valle DD, Del Castillo JM, Fernandez JA. Corneal cross linking and infectious keratitis: a systematic review with a meta-analysis of reported cases. J Ophthalmic Inflamm Infect. 2013;3:47.
21. Cheng KH, Leung SL, Hoekman HW, et al. Incidence of contact-lens- associated microbial keratitis and its related morbidity. Lancet. 1999;354:181-185. (Pubitemid 29329155)
22. Gonzales CA, Srinivasan M, Whitcher JP, Smolin G. Incidence of corneal ulceration in Madurai district, South India. Ophthalmic Epidemiol. 1996;3:159-166. (Pubitemid 26418318)
23. Whitcher JP, Srinivasan M. Corneal ulceration in the developing world: a silent epidemic. Br J Ophthalmol. 1997;81:622-623. (Pubitemid 27429923)
24. Keay L, Edwards K, Naduvilath T, et al. Microbial keratitis predisposing factors and morbidity. Ophthalmology. 2006;113:109-116. (Pubitemid 43021736)